Skip to main content

Radiographic Imaging End Points in Rheumatoid Arthritis Trials

  • Chapter

Part of the book series: Clinical Trials ((CLINICAL))

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Steinbrocker O, Traeger CH, Batterman RC. (1949). Therapeutic criteria in rheumatoid arthritis. JAMA 140(8):659–662.

    CAS  Google Scholar 

  2. Sharp JT, Lidsky MD, Collins LS, Moreland J. (1971). Methods of scoring radiologic changes in rheumatoid arthritis: correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheuma 14:706–720.

    Article  CAS  Google Scholar 

  3. Larsen A, Dale K, Eek M. (1977). Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 18:481–491.

    CAS  Google Scholar 

  4. Boers M. (2000). Value of magnetic resonance imaging in rheumatoid arthritis? Lancet 356:1458–1459.

    Article  PubMed  CAS  Google Scholar 

  5. Lassere MND, Bird P. (2001). Measurement of rheumatoid arthritis disease activity and damage using magnetic resonance imaging. Truth and discrimination: does MRI make the grade? J Rheumatol 28:1151–1157.

    PubMed  CAS  Google Scholar 

  6. Angwin A, Heald G, Lloyd A, Howland K, Davy M, James M. (2001). Reliability and sensitivity of joint space measurements in hand radiographs using computerized image analysis. J Rheumatol 28:1825–1836.

    PubMed  CAS  Google Scholar 

  7. van der Heijde DM. (1989). Effects of hydroxychloroquine and sulfasalazine on progression of joint damage in rheumatoid arthritis. Lancet 1:1036–1038.

    PubMed  Google Scholar 

  8. Genant H (1983). Methods of assessing radiographic change in rheumatoid arthritis. Am J Med 75:35–47.

    Article  PubMed  CAS  Google Scholar 

  9. Scott DL, Houssien DA, Laasonen L. (1995). Proposed modification to Larsen’s scoring methods for hand and wrist radiographs. Br J Rheumatol 34:56.

    Article  PubMed  CAS  Google Scholar 

  10. Rau R, Herborn G. (1995). A modified version of Larsen’s scoring method to assess radiologic changes in rheumatoid arthritis. J Rheumatol 22:1976–1982.

    PubMed  CAS  Google Scholar 

  11. Bathon JM, Martin RW, Fleischmann RM, et al. (2000). A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 343(22):1586–1593.

    Article  PubMed  CAS  Google Scholar 

  12. Sharp JT, Strand V, Leung H, et al. (2000). Treatment with leflunomide slows radiographic progression of rheumatoid arthiritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Am Coll Rheumatol 43(3):495–505.

    CAS  Google Scholar 

  13. Lipsky P, van der Heijde DMFM, St Clair EW, et al. (2000). Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med 343(22):1594–1602.

    Article  PubMed  CAS  Google Scholar 

  14. van der Heijde D, Landewé R, Klareskog L, Rodríguez-Valverde V, Settas L, Pedersen R, Fatenejad S. (2005). Presentation and analysis of radiographic outcome in clinical trials: experience from the TEMPO trial. Arthritis Rheum 52:49–60.

    Article  PubMed  Google Scholar 

  15. van Everdingen AA, Jacobs JWG, van Reesema DRS, et al. (2002). Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial. Ann Intern Med 136:1–12.

    PubMed  Google Scholar 

  16. Kellgren JH, Lawrence JS. (1957). Radiological assessment of rheumatoid arthritis. Ann Rheum Dis 16:485–493.

    Article  PubMed  CAS  Google Scholar 

  17. Kellgren JH, Jeffrey MR, Ball J. (1963). The epidemiology of chronic rheumatism. In: Atlas of Standard Radiographs of Arthritis. Vol. II. Oxford: Blackwell, pp. 22–32.

    Google Scholar 

  18. van der Heijde DM. (1996). Plain X-rays in rheumatoid arthritis: overview of scoring methods, their reliability and applicability. Baillieres Clin Rheumatol 10(3):435–453.

    Article  PubMed  Google Scholar 

  19. Larsen A, Dale K. (1977). Standardized radiological evaluation of rheumatoid arthritis in therapeutic trials. In: Dumonde DC, Jasani JK, eds. Recognition of Anti-Rheumatic Drugs. Lancaster, PA: MTP Press, pp. 285–292.

    Google Scholar 

  20. Larsen A, Horton J, Howland C. (1984). The effects of auranofin and parenteral gold in the treatment of rheumatoid arthritis: an X-ray analysis. Clin Rheumatol 3(Suppl 1):97–104.

    PubMed  Google Scholar 

  21. Larsen A, Thoen J. (1987). Hand radiography of 200 patients with rheumatoid arthritis after an interval of one year. Scand J Rheumatol 16:395–401.

    Article  PubMed  CAS  Google Scholar 

  22. Larsen A. (1995). How to apply Larsen score in evaluating radiographs of rheumatoid arthritis in long-term studies. J Rheumatol 22:1974–1975.

    PubMed  CAS  Google Scholar 

  23. Sharp JT, Young DY, Bluhm GB, et al. (1985). How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 28:1326–1335.

    Article  PubMed  CAS  Google Scholar 

  24. Kaye JJ, Callahan LF, Nance EP, et al. (1987). Rheumatoid arthritis: explanatory power of specific radiographic findings for clinical status. Radiology 1987;165:753–758.

    PubMed  CAS  Google Scholar 

  25. Boini S, Guillemin F. (2001). Radiographic scoring methods as outcome measures in rheumatoid arthritis: properties and advantages. Ann Rheum Dis 60:817–827.

    PubMed  CAS  Google Scholar 

  26. Genant H, Jiang, Y, Peterfy C, Lu Y, Redei J, Countryman P. (1998). Assessment of rheumatoid arthritis using a modified scoring method in digitized and original radiographs. Arthritis Rheum 41(9):1583–1590.

    Article  PubMed  CAS  Google Scholar 

  27. Rau R, Wassenberg S, Herborn G, Stucki G, Gebler A. (1998). A new method of scoring radiographic change in rheumatoid arthritis. J Rheumatol 25:2094–2107.

    PubMed  CAS  Google Scholar 

  28. van der Heijde DM, Dankert T, Nieman F, Rau R, Boers M. (1999). Reliability and sensitivity to change of a simplification of the Sharp/van der Heijde radiological assessment in rheumatoid arthritis. Rheumatology 38:941–947.

    Article  PubMed  Google Scholar 

  29. Wolfe F, van der Heijde DM, Larsen A. (2000). Assessing radiographic status of rheumatoid arthritis: introduction of a short erosion scale. J Rheumatol 27:2090–2099.

    PubMed  CAS  Google Scholar 

  30. Lassere M, Boers M, van der Heijde D, et al. (1999). Smallest detectable difference in radiological progression. J Rheumatol 26:731–739.

    PubMed  CAS  Google Scholar 

  31. Scott DL. (2004). Radiological progression in established rheumatoid arthritis. J Rheumatol 31(Suppl 69):55–65.

    Google Scholar 

  32. Bruynesteyn K, van der Heijde D, Boers M, et al. (2004). The Sharp/van der Heijde method out-performed the Larsen/Scott method on the individual patient level in assessing radiographs in early rheumatoid arthritis. J Clin Epidemiol 57(5):502–512.

    Article  PubMed  Google Scholar 

  33. FDA. (1999, February). Guidance for Industry. Clinical development programs for drugs, devices, and biological products for the treatment of rheumatoid arthritis (RA). Bethesda, MD: U.S. FDA.

    Google Scholar 

  34. FDA. (2000, July). Briefing Document for Arthritis Advisory Committee. Discussion and consideration of proposed radiographic outcome measures for investigational agents for the treatment of rheumatoid arthritis. Available at http://www.fda.gov/ ohrms/dockets/ac/00/questions/3623q2.pdf. Accessed January 20, 2003.

    Google Scholar 

  35. Bruynesteyn K, Landewé R, van der Linden S, van der Heijde D. (2004). Radiography as primary outcome in rheumatoid arthritis: acceptable sample sizes for trials with 3 months’ follow- up. Ann Rheum Dis 63(11):1413–1418.

    Article  PubMed  CAS  Google Scholar 

  36. Bruynesteyn K, van der Heijde D, Boers M, et al. (2002). Detecting radiological changes in rheumatoid arthritis that are considered important by clinical experts: influence of reading with or without known sequence. J Rheumatol 29:2306–2312.

    PubMed  Google Scholar 

  37. van der Heijde D, Landewe R. (2003). Imaging: do erosions heal? Ann Rheum Dis 62(Suppl 2):ii10–12.

    PubMed  Google Scholar 

  38. Rau R, Wassenberg S, Herborn G, Perschel W, Freitag G. (2001). Identification of radiological healing phenomena in patients with rheumatoid arthritis. J Rheumatol 28:2608–2615.

    PubMed  CAS  Google Scholar 

  39. Sharp J, van der Heijde D, Boers M, et al., for the Subcommittee on Healing of Erosions of the OMERACT Imaging Committee. (2003). Repair of erosions in rheumatoid arthritis does occur. Results from two studies by the OMERACT subcommittee on healing of erosions. J Rheumatol 30(5):1102–1107.

    PubMed  Google Scholar 

  40. van der Heijde D, Sharp J, Rau R, Strand V, on behalf of subcommittee on healing of erosions of the OMERACT imaging committee. (2003). OMERACT Workshop: repair of structural damage in rheumatoid arthritis. J Rheumatol 30(5):1108–1109.

    Google Scholar 

  41. van der Heijde D, Landewé R, Winalski C, Weissman B, Wassenberg S, Rau R, Herborn G, Einstein E, Boonen A, Sharp JT. (2004). Erosion repair in RA is recognised by expert readers but cannot be distinguished from progression by specific features. Arthritis Rheum 50(9 Suppl):S167.

    Google Scholar 

  42. Landewé R, van der Heijde D, Boonen A, Einstein E, Herborn G, Rau R, Wassenberg S, Weissman B,Winalski C, Sharp JT. (2004). Providing readers with films of the entire hand or foot compared to single joints does not improve discrimination between progression and repair in RA. Arthritis Rheum 50(9 Suppl):S174.

    Google Scholar 

  43. van der Heijde DM, Simon L, Smolen J, et al. (2002). How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion. Arthritis Rheum 47:215–218.

    Article  PubMed  Google Scholar 

  44. van der Heijde D, Landewé R, Klareskog L, et al. (2005). Presentation and analysis of radiographic outcome in clinical trials: experience from the TEMPO trial. Arthritis Rheum 52: 49–60.

    Article  PubMed  Google Scholar 

  45. Landewé R, van der Heijde D. (2004). Radiographic progression depicted by probability plots: presenting data with optimal use of individual values. Arthritis Rheum 50(3):699–706.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Baratelle, A.M., Heijde, D.v. (2008). Radiographic Imaging End Points in Rheumatoid Arthritis Trials. In: Reid, D.M., Miller, C.G. (eds) Clinical Trials in Rheumatoid Arthritis and Osteoarthritis. Clinical Trials. Springer, London. https://doi.org/10.1007/978-1-84628-742-8_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-742-8_13

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-85233-874-9

  • Online ISBN: 978-1-84628-742-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics